Who owns LISATA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Lisata Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lisata Therapeutics stock

Who bought or sold LISATA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 271k $709k 6% Sep 2025
 View chart
Renaissance Technologies 117k $306k 13% Sep 2025
 View chart
BML Capital Management 110k $288k -48% Sep 2025
 View chart
Geode Capital Management 63k $166k 4% Sep 2025
 View chart
BlackRock 55k $144k 0% Sep 2025
 View chart
Ground Swell Capital 24k $62k 100% Sep 2025
 View chart
Dimensional Fund Advisors 21k $55k -19% Sep 2025
 View chart
State Street Corporation 14k $38k 0% Sep 2025
 View chart
HPM Partners 12k $31k 0% Sep 2025
 View chart
XTX Topco 11k $29k 100% Sep 2025
 View chart
Northern Trust 10k $27k 0% Sep 2025
 View chart
HighTower Advisors 10k $26k 0% Sep 2025
 View chart
Royal Bank of Canada 5.9k $0 0% Sep 2025
 View chart
Founders Capital Management 2.0k $5.2k 0% Sep 2025
 View chart
Tower Research Capital 1.7k $4.4k 26% Sep 2025
 View chart
Connective Capital Management 1.0k $2.7k 100% Sep 2025
 View chart
Morgan Stanley 224.00 $649.174400 100% Jun 2025
 View chart
SBI Securities 140.00 $366.996000 0% Sep 2025
 View chart
Barclays 4.00 $10.000000 0% Sep 2025
 View chart
Chevoit Value Management 3.00 $8.000100 0% Sep 2025
 View chart

Who sold out of Lisata Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Cook Wealth Management Group Mar 2025 12k $29k
UBS Group Jun 2025 7.1k $21k
Jpmorgan Chase & Co Mar 2025 13.00 $30.999800
Raymond James Financial Jun 2025 6.00 $16.999800